Data from Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report
Authors:
- Navin PintoNPNavin Pinto
- Arlene NaranjoANArlene Naranjo
- Xiangming DingXDXiangming Ding
- Fan F. ZhangFZFan F. Zhang
- Emily HibbittsEHEmily Hibbitts
- Rebekah KennedyRKRebekah Kennedy
- Rachelle TibbettsRTRachelle Tibbetts
- Shannon Wong-MichalakSWShannon Wong-Michalak
- David W. CraigDCDavid W. Craig
- Zarko ManojlovicZMZarko Manojlovic
- Michael D. HogartyMHMichael D. Hogarty
- Susan KreissmanSKSusan Kreissman
Open Access
- 25 November 2025
- other
- Published by American Association for Cancer Research (AACR)